Science Explorer Back to mapMap
Discussion
Company · San Mateo · United States

Deltagen (United States)

deltagen.comROR OpenAlex
Research works
25
▲ 94% vs 2018-21
Citations
1.5k
59.5 per fractional work
Top-10% rate
9.5%
all institutions 10.0%
Open access
46%
world 40%
International
24%
world 18%
Deltagen (United States)

Not ranked overall: Deltagen (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Deltagen (United States) work in?

In all years, 41% of research at Deltagen (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (34%), Chemistry (14%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 41.2% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 33.7% of its workMolecular Biology: 7 fractional works · 26.3% of its workGenetics: 1 fractional works · 3.6% of its workBiochemistry: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 1.2% of its workBiophysics: 0 fractional works · 0.7% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 5.4% of its workImmunology: 1 fractional works · 5.4% of its workNeuroscience: 0 fractional works · 1.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.8% of its workHealth Sciences: 9 fractional works · 33.9% of its workMedicine: 9 fractional works · 33.9% of its workGenetics: 2 fractional works · 7.5% of its workOncology: 2 fractional works · 6.4% of its workHematology: 1 fractional works · 3.1% of its workPathology and Forensic Medicine: 1 fractional works · 3.0% of its workPhysiology: 0 fractional works · 1.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.6% of its workImmunology and Allergy: 0 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.3% of its workSurgery: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.8% of its workNephrology: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workGastroenterology: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysical Sciences: 6 fractional works · 22.6% of its workChemistry: 3 fractional works · 13.7% of its workOrganic Chemistry: 3 fractional works · 12.5% of its workSpectroscopy: 0 fractional works · 0.7% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.5% of its workComputer Science: 1 fractional works · 3.3% of its workComputational Theory and Mathematics: 1 fractional works · 3.3% of its workMathematics: 1 fractional works · 2.6% of its workStatistics and Probability: 0 fractional works · 1.6% of its workModeling and Simulation: 0 fractional works · 1.0% of its workEngineering: 0 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 1.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 2.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.3% of its workEconomics and Econometrics: 0 fractional works · 1.3% of its workPsychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.9% of its workALL ITS WORKDeltagen (UnitedStates)25fractional works, all years
Life Sciences41%Physical Sciences23%Health Sciences34%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology933.7%
    2. Immunology and Microbiology15.4%
    3. Neuroscience01.3%
    4. Agricultural and Biological Sciences00.8%
    1. Medicine933.9%
    1. Chemistry313.7%
    2. Computer Science13.3%
    3. Mathematics12.6%
    4. Engineering01.4%
    5. Environmental Science00.7%
    6. Materials Science00.7%
    7. Physics and Astronomy00.3%
    1. Economics, Econometrics and Finance01.3%
    2. Psychology00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.07× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.54× its world share, 0 worksImmunology and Micro…Neuroscience: 0.27× its world share, 0 worksNeuroscienceMathematics: 9.88× its world share, 0 worksMathematicsMedicine: 3.74× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 3.61× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 9.9×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Mathematics9.88×0 works
  2. Medicine3.74×3 works
  3. Economics, Econometrics and Finance3.61×0 works
  4. Immunology and Microbiology2.54×0 works
  5. Biochemistry, Genetics and Molecular Biology1.07×0 works
  6. Neuroscience0.27×0 works

Who are the top researchers at Deltagen (United States)?

Ranked on the quality score, Winston Thomas lead among researchers whose main affiliation is Deltagen (United States).

  1. 1 Winston Thomas United States · #1,588,199 worldwide 1.3k citations · 22 works
All ranked researchers at Deltagen (United States)

What are the most cited papers from Deltagen (United States)?

The most cited paper from Deltagen (United States) is "An integrative genomics approach to infer causal associations between gene expression and disease" (Eric E. Schadt et al., 2005), with 1,091 citations. Next come "GFRα1 Is an Essential Receptor Component for GDNF in the Developing Nervous System and Kidney" (566) and "Loss of Nuclear Receptor SHP Impairs but Does Not Eliminate Negative Feedback Regulation of Bile Acid Synthesis" (353).

Most cited papers
#PaperReleasedCitations
1 An integrative genomics approach to infer causal associations between gene expression and disease Eric E. Schadt et al. · Nature Genetics Open access 19 Jun 2005 1,091
2 GFRα1 Is an Essential Receptor Component for GDNF in the Developing Nervous System and Kidney Grace Cacalano, Isabel Fariñas, Li-Chong Wang et al. · Neuron Open access Jul 1998 566
3 Loss of Nuclear Receptor SHP Impairs but Does Not Eliminate Negative Feedback Regulation of Bile Acid Synthesis Thomas A. Kerr, Shigeru Saeki, Manfred P Schneider et al. · Developmental Cell Open access Jun 2002 353
4 The G s -Linked Receptor GPR3 Maintains Meiotic Arrest in Mammalian Oocytes Lisa M. Mehlmann, Yoshinaga Saeki, Shigeru Tanaka et al. · Science 10 Dec 2004 336
5 A Genome-wide Drosophila Screen for Heat Nociception Identifies α2δ3 as an Evolutionarily Conserved Pain Gene G. Gregory Neely et al. · Cell Open access Nov 2010 327
All 72 most cited papers, with filters and sorting

Which keywords describe research at Deltagen (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Drug Discovery, Cancer, Therapeutic Targets, Rituximab, Synthesis, Medicinal Chemistry, Inflammation and Prognostic Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Cancer3▲ 7.3×12 topics
  2. Drug Discovery2▲ 25×6 topics
  3. Inflammation2▲ 4.1×14 topics
  4. Therapeutic Targets2▲ 41×3 topics
  5. Rituximab2▲ 55×2 topics
  6. Medicinal Chemistry2▲ 21×4 topics
  7. Synthesis2▲ 14×3 topics
  8. Prognostic Factors2▲ 15×4 topics
  9. Chronic Lymphocytic Leukemia2▲ 125×1 topic
  10. Genomic Aberrations2▲ 125×1 topic
  11. Molecular Docking2▲ 42×2 topics
  12. Biological Evaluation1▲ 43×2 topics
  13. Heterocycles1▲ 29×2 topics
  14. Machine Learning1▲ 2.2×4 topics
  15. Stem Cells1▲ 14×4 topics
  16. Anticancer Agents1▲ 16×2 topics
  17. Gene Therapy1▲ 15×3 topics
  18. Heterocyclic Compounds1▲ 25×2 topics
  19. Transcriptional Regulation1▲ 16×4 topics

Which research topics does Deltagen (United States) publish most on?

By volume in 2022-now: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers and Economic and Financial Impacts of Cancer.

Chronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksEconomic and Financial Impacts of Cancer: 0 fractional worksMathematical Biology Tum…0Mathematical Biology Tumor Growth: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksCAR-T cell therapy research: 0 fractional worksStatistical Methods in Clinical Trials: 0 fractional worksFrailty in Older Adults: 0 fractional worksCardiac, Anesthesia and Surgical Outcomes: 0 fractional works
GeneticsPathology and Forensic MedicineOncologyEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 1 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  5. 5 Mathematical Biology Tumor Growth Modeling and Simulation 0 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  9. 9 Frailty in Older Adults Geriatrics and Gerontology 0 works
  10. 10 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.1%not open53.9%

World: 40% of research is openly available.

with international co-authors24.1%domestic only75.9%

World: 18% is written across borders.

How has Deltagen (United States)'s research output changed?

Output in 2022-2025 was 94% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Deltagen (United States) as a percentage of every work published that year, 0.000037% in 2024.

still counting0.00020%0.00040%Deltagen (United States)0.0000066% in 2025200020102020

Fractional works of Deltagen (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Mateo

All research institutions in San Mateo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Deltagen (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.